Lord, Abbett & Co’s Ascendis Pharma A/S ASND Stock Holding History

Lord, Abbett & Co’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.5M	Sell	144,468 -849	-0.6%	-$198K	0.11%	214
2026 Q1	$33.2M	Buy	145,317 +25,120	+21%	+$5.63M	0.11%	207
2025 Q4	$25.6M	Sell	120,197 -31,230	-21%	-$6.45M	0.08%	245
2025 Q3	$30.1M	Sell	151,427 -2,749	-2%	-$513K	0.09%	235
2025 Q2	$26.6M	Buy	+154,176	New	+$25.1M	0.09%	242
2018 Q3	–	Sell	-146,403	Closed	-$9.74M	–	826
2018 Q2	$9.74M	Sell	146,403 -58,304	-28%	-$3.83M	0.03%	630
2018 Q1	$13.4M	Sell	204,707 -47,991	-19%	-$2.7M	0.04%	570
2017 Q4	$10.1M	Sell	252,698 -5,955	-2%	-$217K	0.03%	620
2017 Q3	$9.38M	Buy	+258,653	New	+$7.42M	0.03%	649

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lord, Abbett & Co's ASND Position: Q2 2026 in Review

Lord, Abbett & Co reduced its Ascendis Pharma A/S (ASND) stake by 0.58% in Q2 2026, selling an estimated $198K and leaving 144,468 shares worth $38.5M. The position accounts for 0.11% of the portfolio, ranked #214.

Lord, Abbett & Co first reported a position in ASND in Q3 2017 and has held it in 9 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Lord, Abbett & Co held 144,468 shares of Ascendis Pharma A/S worth $38.5M as of Q2 2026.
Lord, Abbett & Co sold 849 Ascendis Pharma A/S shares in Q2 2026, an estimated $198K.
Ascendis Pharma A/S made up 0.11% of Lord, Abbett & Co's portfolio in Q2 2026, its #214 holding.
Lord, Abbett & Co first reported a position in Ascendis Pharma A/S in Q3 2017 and has held it in 9 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.